Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H32O7 |
Molecular Weight | 432.5067 |
Optical Activity | UNSPECIFIED |
Additional Stereochemistry | Yes |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | AXIAL, R |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C(OC)=C1OC)C3=C(OC)C(OC)=C(OC)C=C3C[C@](C)(O)[C@@H](C)C2
InChI
InChIKey=YEFOAORQXAOVJQ-RZFZLAGVSA-N
InChI=1S/C24H32O7/c1-13-9-14-10-16(26-3)20(28-5)22(30-7)18(14)19-15(12-24(13,2)25)11-17(27-4)21(29-6)23(19)31-8/h10-11,13,25H,9,12H2,1-8H3/t13-,24-/m0/s1
Schisandrin is a bioactive compound found in Schisandra chinensis. Schisandrin exhibits antioxidant properties and ameliorates ovariectomy-induced memory impairment in rats, and Aβ1-42-induced memory impairment in mice. Schisandrin has an anti-asthmatic effect on OVA-induced airway inflammation in a murine asthma model. The compound inhibits proliferation of breast cancer cell lines at concentrations of 20-100 uM.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22829961
Curator's Comment: Ameliorates memory impairment in rats and mice
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P25105 Gene ID: 5724.0 Gene Symbol: PTAFR Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/10220282 |
250.0 µM [IC50] | ||
Target ID: GO:1903409 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20727999 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Bioactivity of neolignans from fructus Schizandrae. | 1991 |
|
Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. | 1999 Mar |
|
Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells. | 2010 Feb |
|
Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model. | 2010 Nov |
|
Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. | 2015 Apr 25 |
|
Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties. | 2015 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25573619
In a study of cognitive dysfunction in ovariectomized rats schizandrin was administered orally at 10 and 30 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19585470
Effect of schisandrin on proliferation of breast cancer cell lines was determined with the sulforhodamine B protein staining method. T47D and MDA-MB-213 cells were treated with 0.8 - 100 uM of schisandrin for 3 days.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
G01BQC0879
Created by
admin on Sat Dec 16 11:08:22 GMT 2023 , Edited by admin on Sat Dec 16 11:08:22 GMT 2023
|
PRIMARY | |||
|
3001664
Created by
admin on Sat Dec 16 11:08:22 GMT 2023 , Edited by admin on Sat Dec 16 11:08:22 GMT 2023
|
PRIMARY | |||
|
1609895
Created by
admin on Sat Dec 16 11:08:22 GMT 2023 , Edited by admin on Sat Dec 16 11:08:22 GMT 2023
|
PRIMARY | |||
|
7432-28-2
Created by
admin on Sat Dec 16 11:08:22 GMT 2023 , Edited by admin on Sat Dec 16 11:08:22 GMT 2023
|
PRIMARY | |||
|
DTXSID20995843
Created by
admin on Sat Dec 16 11:08:22 GMT 2023 , Edited by admin on Sat Dec 16 11:08:22 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD